Ex-Editas CEO Katrine Bosley chairs Arrakis board; Cardurion touts Polaris investment
→ After a surprise exit from Editas Medicine in January — which left many in shock and the stock plunging 21% $EDIT — ex-CEO Katrine Bosley …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.